| Net Cash Provided by (Used in) Operating Activities |
$920,485 |
USD |
-19% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$2,756,520 |
USD |
3181% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$160,779 |
USD |
69% |
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
160,000,000 |
shares |
-67% |
Q2 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
150,000,000 |
shares |
198% |
Q2 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,675,256 |
USD |
|
Q4 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$584,365 |
USD |
99% |
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,699,000 |
USD |
55% |
Q3 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$1,699,000 |
USD |
55% |
Q3 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,391,049 |
USD |
36% |
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,699,000 |
USD |
55% |
Q3 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
10,000,000 |
shares |
|
Q2 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Additional Paid in Capital |
$36,040,611 |
USD |
36% |
Q2 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$1,086,543 |
USD |
-59% |
Q2 2025 |
Q3 2025 |
| Interest Expense |
$982,691 |
USD |
941% |
Q1 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |